Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.

作者: Gerard Sanacora , Ralitza Gueorguieva , C. Neill Epperson , Yu-Te Wu , Michael Appel

DOI: 10.1001/ARCHPSYC.61.7.705

关键词:

摘要: Background Measurement of cortical γ-aminobutyric acid (GABA) and glutamate concentrations is possible using proton magnetic resonance spectroscopy. An initial report, this technique, suggested that occipital cortex GABA are reduced in patients with major depressive disorder (MDD) relative to healthy comparison subjects. Objectives To replicate the findings a larger sample MDD patients, examine clinical correlates reductions these subjects, other critical metabolite levels. Design Study for association. Setting Academic research program. Participants The measurements were made on 38 control subjects 33 depressed Interventions Occipital levels measured Main Outcome Measures GABA, glutamate, N -acetylaspartate, aspartate, creatine, choline-containing compounds, along several measures tissue composition, compared between 2 groups. Results Depressed had significantly lower controls ( P = .01). In addition, mean increased .009) percentage white matter .04) voxel also observed. examination combined database including from original study suggests differ among subtypes. Conclusions replicates decreased MDD. It demonstrates there change ratio excitatory-inhibitory neurotransmitter may be related altered brain function. Last, data set spectroscopy serve as biological marker subtype

参考文章(70)
Vladimir Coric, Snezana Milanovic, Suzanne Wasylink, Pinal Patel, Robert Malison, John H. Krystal, Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder Psychopharmacology. ,vol. 167, pp. 219- 220 ,(2003) , 10.1007/S00213-003-1396-Z
G. Tunnicliff, Central GABAergic systems and depressive illness. Neurochemical Research. ,vol. 28, pp. 965- 976 ,(2003) , 10.1023/A:1023287729363
Shu-chi Hsiung, Mella Adlersberg, Victoria Arango, J. John Mann, Hadassah Tamir, Kuo-peing Liu, Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase Journal of Neurochemistry. ,vol. 87, pp. 182- 194 ,(2003) , 10.1046/J.1471-4159.2003.01987.X
P. J. Magistretti, Energy on Demand Science. ,vol. 283, pp. 496- 497 ,(1999) , 10.1126/SCIENCE.283.5401.496
Hans Jörgen Grabe, Norbert Ahrens, Hans-Joachim Rose, Christof Kessler, Harald Jürgen Freyberger, Neurotrophic Factor S100beta in Major Depression Neuropsychobiology. ,vol. 44, pp. 88- 90 ,(2001) , 10.1159/000054922
D. Ongur, W. C. Drevets, J. L. Price, GLIAL REDUCTION IN THE SUBGENUAL PREFRONTAL CORTEX IN MOOD DISORDERS Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 13290- 13295 ,(1998) , 10.1073/PNAS.95.22.13290
José Javier Miguel-Hidalgo, Christie Baucom, Ginny Dilley, James C Overholser, Herbert Y Meltzer, Craig A Stockmeier, Grazyna Rajkowska, Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder Biological Psychiatry. ,vol. 48, pp. 861- 873 ,(2000) , 10.1016/S0006-3223(00)00999-9
Rafael Stryjer, Rael D. Strous, Ginette Shaked, Faina Bar, Boris Feldman, Moshe Kotler, Lea Polak, Silvio Rosenzcwaig, Abraham Weizman, Amantadine as augmentation therapy in the management of treatment-resistant depression International Clinical Psychopharmacology. ,vol. 18, pp. 93- 96 ,(2003) , 10.1097/00004850-200303000-00005
David R Cotter, Carmine M Pariante, Ian P Everall, Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Research Bulletin. ,vol. 55, pp. 585- 595 ,(2001) , 10.1016/S0361-9230(01)00527-5
I-Shin Shiah, Lakshmi N. Yatham, GABA function in mood disorders: an update and critical review. Life Sciences. ,vol. 63, pp. 1289- 1303 ,(1998) , 10.1016/S0024-3205(98)00241-0